[go: up one dir, main page]

ZA200407986B - Substituted phenylacetamides and their use as glucokinase activators. - Google Patents

Substituted phenylacetamides and their use as glucokinase activators.

Info

Publication number
ZA200407986B
ZA200407986B ZA200407986A ZA200407986A ZA200407986B ZA 200407986 B ZA200407986 B ZA 200407986B ZA 200407986 A ZA200407986 A ZA 200407986A ZA 200407986 A ZA200407986 A ZA 200407986A ZA 200407986 B ZA200407986 B ZA 200407986B
Authority
ZA
South Africa
Prior art keywords
glucokinase activators
substituted phenylacetamides
phenylacetamides
substituted
glucokinase
Prior art date
Application number
ZA200407986A
Other languages
English (en)
Inventor
Wendy Lea Corbett
Nancy-Ellen Haynes
Paige Erin Mahaney
Ramakanth Sarabu
Joseph Samuel Grimsby
Robert Francis Kester
Racha Francis
Kumar Jagdish
Ka Wang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200407986B publication Critical patent/ZA200407986B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/50—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200407986A 2002-04-26 2004-10-04 Substituted phenylacetamides and their use as glucokinase activators. ZA200407986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37616102P 2002-04-26 2002-04-26

Publications (1)

Publication Number Publication Date
ZA200407986B true ZA200407986B (en) 2005-10-18

Family

ID=29420328

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200407986A ZA200407986B (en) 2002-04-26 2004-10-04 Substituted phenylacetamides and their use as glucokinase activators.

Country Status (34)

Country Link
US (2) US7105671B2 (fr)
EP (1) EP1501815B1 (fr)
JP (1) JP4091600B2 (fr)
KR (1) KR100669587B1 (fr)
CN (1) CN1329386C (fr)
AR (1) AR039665A1 (fr)
AT (1) ATE346056T1 (fr)
AU (1) AU2003232204B8 (fr)
BR (1) BR0309546A (fr)
CA (1) CA2482346C (fr)
DE (1) DE60309856T2 (fr)
DK (1) DK1501815T3 (fr)
EA (1) EA011297B1 (fr)
EC (1) ECSP045382A (fr)
ES (1) ES2276097T3 (fr)
GT (1) GT200300096A (fr)
HR (1) HRP20040953A2 (fr)
IL (1) IL164780A (fr)
MA (1) MA27113A1 (fr)
MX (1) MXPA04010605A (fr)
MY (1) MY135222A (fr)
NO (1) NO20044534L (fr)
NZ (1) NZ535706A (fr)
PA (1) PA8572301A1 (fr)
PE (1) PE20040451A1 (fr)
PL (1) PL373701A1 (fr)
PT (1) PT1501815E (fr)
RS (1) RS93604A (fr)
TN (1) TNSN04211A1 (fr)
TW (1) TWI281917B (fr)
UA (1) UA80427C2 (fr)
UY (1) UY27787A1 (fr)
WO (1) WO2003095438A1 (fr)
ZA (1) ZA200407986B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04115996U (ja) * 1991-03-28 1992-10-15 東洋運搬機株式会社 ボートリフタ
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
NZ539013A (en) 2002-10-03 2007-05-31 Novartis Ag Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
RU2392275C2 (ru) 2004-02-18 2010-06-20 Астразенека Аб Бензамидные производные и их применение в качестве активирующих глюкокиназу агентов
RU2412192C2 (ru) 2004-04-02 2011-02-20 Новартис Аг Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2
MXPA06011365A (es) 2004-04-02 2006-12-15 Novartis Ag Derivados de tiazolo-piridina, composiciones farmaceuticas que los contienen, y metodos para el tratamiento de condiciones mediadas por glucoquinasa.
CA2563192A1 (fr) * 2004-04-21 2005-11-03 Prosidion Limited Composes amide tri(cyclo)-substitues
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
CA2576407A1 (fr) * 2004-08-12 2006-02-16 Prosidion Limited Phenylacetamides substitues et leur utilisation en tant qu'activateurs de la glucokinase
GB0418046D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Eantioselective process
GB0418058D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Fluorination process
WO2007007041A1 (fr) 2005-07-09 2007-01-18 Astrazeneca Ab Dérivés d’hétéroaryl benzamide utilisés en tant qu’activateurs de la glk dans le traitement du diabète
JP4033409B1 (ja) 2005-07-11 2008-01-16 田辺三菱製薬株式会社 オキシム誘導体及びその製法
KR20080040046A (ko) 2005-08-31 2008-05-07 아스텔라스세이야쿠 가부시키가이샤 티아졸 유도체
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
RU2008112198A (ru) 2005-09-29 2009-10-10 Санофи-Авентис (Fr) Производные фенил-1,2,4-оксадиазолона, способы их получения и их применение в качестве фармацевтических средств
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
WO2007048717A1 (fr) 2005-10-24 2007-05-03 F. Hoffmann-La Roche Ag Preparation de cetones cetalisees, cycliques, par rearrangement de favorskii et leur utilisation pour la preparation d'un activateur de la glucokinase 70
US20080293741A1 (en) * 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
WO2007104034A2 (fr) 2006-03-08 2007-09-13 Takeda San Diego, Inc. Activateurs de la glucokinase
WO2007115968A2 (fr) * 2006-04-12 2007-10-18 F. Hoffmann-La Roche Ag Procédé de préparation d'un activateur de glucokinase
WO2007115967A1 (fr) * 2006-04-12 2007-10-18 F. Hoffmann-La Roche Ag Solvate d'isopropanol cristallin de l'activateur de la glucokinase
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP2049518B1 (fr) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Derives de l'indazole et de l'isoindazole comme agents de l'activation de glucokinase
NZ574038A (en) 2006-06-27 2011-12-22 Takeda Pharmaceutical Fused cyclic compounds as GPR40 receptor function modulators, for treating diabetes
US7910747B2 (en) 2006-07-06 2011-03-22 Bristol-Myers Squibb Company Phosphonate and phosphinate pyrazolylamide glucokinase activators
US7888504B2 (en) 2006-07-06 2011-02-15 Bristol-Myers Squibb Company Glucokinase activators and methods of using same
WO2008012227A2 (fr) 2006-07-24 2008-01-31 F. Hoffmann-La Roche Ag Pyrazoles comme activateurs de glucokinase
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
SA07280576B1 (ar) 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
US7902248B2 (en) * 2006-12-14 2011-03-08 Hoffmann-La Roche Inc. Oxime glucokinase activators
WO2008074694A1 (fr) * 2006-12-20 2008-06-26 F. Hoffmann-La Roche Ag Cristallisation d'activateurs de glucokinase
EP2091947A2 (fr) 2006-12-20 2009-08-26 Takeda San Diego, Inc. Activateurs de glucokinase
TW200831081A (en) * 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
WO2008080824A1 (fr) * 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Cétales aromatiques sulfonés
WO2008080822A1 (fr) * 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Méthodologies d'épimérisation permettant le recueil de stéréoisomères très purs avec un bon rendement
JP5207981B2 (ja) 2007-01-10 2013-06-12 田辺三菱製薬株式会社 ヒドラゾン誘導体
CA2679971C (fr) * 2007-03-07 2015-02-17 Teijin Pharma Limited Activateur de glucokinase
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
CA2700783C (fr) * 2007-10-08 2015-03-17 Advinus Therapeutics Private Limited Derives acetamide comme activateur de la glucokinase, leur procede et applications medicinales
JP5287730B2 (ja) 2008-01-18 2013-09-11 アステラス製薬株式会社 フェニルアセトアミド誘導体
US7741327B2 (en) 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
US8258134B2 (en) * 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
ME02198B (me) * 2008-04-28 2016-02-20 Kyorin Seiyaku Kk Derivati ciklopentilakrilamida
US20110021570A1 (en) * 2009-07-23 2011-01-27 Nancy-Ellen Haynes Pyridone glucokinase activators
US8222416B2 (en) 2009-12-14 2012-07-17 Hoffmann-La Roche Inc. Azaindole glucokinase activators
WO2011123572A1 (fr) 2010-03-31 2011-10-06 The Scripps Research Institute Nouvelle programmation de cellules
US8178689B2 (en) 2010-06-17 2012-05-15 Hoffman-La Roche Inc. Tricyclic compounds
EP2878339A1 (fr) 2013-12-02 2015-06-03 Siena Biotech S.p.A. Antagonistes SIP3
CA3031592A1 (fr) 2016-08-31 2018-03-08 Jiangsu Hengrui Medicine Co., Ltd. Derive d'oxopicolinamide, son procede de preparation et son utilisation pharmaceutique
GB201714777D0 (en) 2017-09-14 2017-11-01 Univ London Queen Mary Agent
WO2019052932A1 (fr) 2017-09-18 2019-03-21 Basf Se Trifluorométhyloxadiazoles substitués permettant de lutter contre des champignons phytopathogènes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE249241C (fr) 1910-05-01 1912-07-13
US3431301A (en) * 1966-03-24 1969-03-04 Hoffmann La Roche Process for producing methylhydrazine derivatives
US3776917A (en) * 1972-06-05 1973-12-04 Schering Corp 2-amino-6-phenalkyl-aminopyridines and derivatives thereof
ES419319A1 (es) 1973-10-04 1976-03-01 Gallardo Antonio Sa Un procedimiento para la obtencion de derivados de acidos 3-benzoilfenilalcanoicos.
GB8909574D0 (en) * 1989-04-26 1989-06-14 Ici Plc Chemical process
US5169951A (en) * 1990-04-23 1992-12-08 Ciba-Geigy Corporation Process for preparing nematicidal compositions
DE69322118T2 (de) 1992-04-17 1999-05-20 Hodogaya Chemical Co., Ltd., Tokio/Tokyo Amino-Thiazolderivate und ihre Anwendung als Fungizide
US5556859A (en) * 1994-12-22 1996-09-17 Dowelanco N-(4-pyrimidinyl)amide pesticides
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
DE60014610T2 (de) * 1999-03-29 2006-03-09 F. Hoffmann-La Roche Ag Glukokinase aktivatoren
KR100556323B1 (ko) * 2000-07-20 2006-03-03 에프. 호프만-라 로슈 아게 알파-아실 및 알파-헤테로원자-치환된 벤젠 아세트아미드글루코키나제 활성화제

Also Published As

Publication number Publication date
ES2276097T3 (es) 2007-06-16
IL164780A (en) 2009-05-04
AU2003232204A1 (en) 2003-11-11
TW200402418A (en) 2004-02-16
EA011297B1 (ru) 2009-02-27
IL164780A0 (en) 2005-12-18
EP1501815A1 (fr) 2005-02-02
CA2482346C (fr) 2010-03-09
HRP20040953A2 (en) 2005-06-30
JP2005535589A (ja) 2005-11-24
MXPA04010605A (es) 2004-12-13
CA2482346A1 (fr) 2003-11-20
TNSN04211A1 (fr) 2007-03-12
MA27113A1 (fr) 2004-12-20
JP4091600B2 (ja) 2008-05-28
TWI281917B (en) 2007-06-01
CN1649859A (zh) 2005-08-03
US7259166B2 (en) 2007-08-21
DE60309856D1 (de) 2007-01-04
UY27787A1 (es) 2003-10-31
AR039665A1 (es) 2005-03-02
AU2003232204B2 (en) 2006-09-14
BR0309546A (pt) 2005-02-15
WO2003095438A1 (fr) 2003-11-20
US7105671B2 (en) 2006-09-12
KR100669587B1 (ko) 2007-01-15
PA8572301A1 (es) 2004-05-26
US20030225283A1 (en) 2003-12-04
GT200300096A (es) 2004-01-15
PT1501815E (pt) 2007-01-31
WO2003095438A9 (fr) 2004-12-23
PL373701A1 (en) 2005-09-05
US20060178429A1 (en) 2006-08-10
DE60309856T2 (de) 2007-06-14
ATE346056T1 (de) 2006-12-15
UA80427C2 (en) 2007-09-25
DK1501815T3 (da) 2007-04-02
AU2003232204B8 (en) 2009-07-30
HK1078088A1 (en) 2006-03-03
PE20040451A1 (es) 2004-07-21
NZ535706A (en) 2007-08-31
EA200401398A1 (ru) 2005-06-30
KR20040104633A (ko) 2004-12-10
ECSP045382A (es) 2005-01-03
EP1501815B1 (fr) 2006-11-22
RS93604A (en) 2007-02-05
MY135222A (en) 2008-02-29
CN1329386C (zh) 2007-08-01
NO20044534L (no) 2004-12-22

Similar Documents

Publication Publication Date Title
ZA200407986B (en) Substituted phenylacetamides and their use as glucokinase activators.
IL181235A0 (en) Substituted phenylacetamides and their use as glucokinase activators
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
SI1455785T1 (sl) Substituirani 2-tio-3,5-diciano-4-fenil-6-aminopiridini in njihova uporaba
EP1539941A4 (fr) Adzymes et leurs utilisations
EP1617807A4 (fr) 1,4-diazepines substituees et leurs utilisations
EG25097A (en) Piprazinyl and diazapanyl benzamides and benzthioamides.
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
SI1551805T1 (sl) Substituirani gama-fenil-delta-laktami in njihova uporaba
ZA200210316B (en) Composition and its therapeutic use.
SI1532141T1 (sl) 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi
TWI348382B (en) N-acetylglucosamine derivatives, and the use thereof
GB0219831D0 (en) Catflap or the like
AU2003231827A8 (en) Pseudo-tissues and uses thereof
EP1517879A4 (fr) Aminoalkylphenols et leurs procedes d'utilisation et de fabrication
SI1501815T1 (sl) substituirani fenilacetamidi in njihova uporaba kot aktivatorji glukokinaze
AU2003300859A8 (en) Carrier-ligand fusions and uses thereof
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
GB0312340D0 (en) Improved game and aricle for use with the game
AU2003216442A8 (en) Enkurin and uses thereof
AU2002335297A1 (en) Tumor tag and the use thereof
GB0202011D0 (en) The Fucker
AU2002238359A1 (en) Tumor tag and the use thereof
SI1572670T1 (sl) Aktivatorji 5-substituirane-pirazin ali -piridin glukokinaze
GB0203535D0 (en) Substituted inositols and their uses